Epidemiology of Sepsis at Yuetan Subdistrict in Beijing

Sepsis Clinical Trial

Official title:

Epidemiology of Sepsis at Yuetan Subdistrict in Beijing

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02285257
• Other study ID #: MICU2014-1
• Secondary ID: Z131107002213112
• Status: Recruiting
• Phase: N/A
• First received: November 4, 2014
• Last updated: November 5, 2014
• Start date: July 2013
• Est. completion date: June 2016

Study information

• Verified date: October 2014
• Source: Peking Union Medical College Hospital
• Contact: Bin Du, professor
• Phone: 8613601366216
• Email: dubin98[@]gmail.com
• Is FDA regulated: No
• Health authority: China: Beijing Municipal Science and Technology CommissionChina: Ethics Committee
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The purpose of this study is to determine the epidemiology and outcome of sepsis at Yuetan subdistrict in Beijing in mainland China).

Description:

1. Questionnaires were used to collect the characteristic information of people living in Yuetan subdistrict in Beijing and select people who had been hospitalized because of any reasons between July 2012 and June 2014.

2. Data were collected on all patients admitted into different hospitals during the study period. The following information was recorded:demographic characteristics and admission category (whether medical, scheduled surgery, nonoperative trauma, or unscheduled surgery), presence of preexisting organ insufficiency,using definitions included in the Acute Physiology and Chronic Health Evaluation (APACHE) II score11; co- morbidities and the estimated prognosis of any preexisting underlying disease, following the classification of McCabe and Jackson.

3. Patients were included in the study cohort when having, in association with a documented or strongly suspected infection and fullfil the diagnostic criteria of sepsis according to the "Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock:2012".

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1000
• Est. completion date: June 2016
• Est. primary completion date: June 2016
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age=18 years;

• Having lived in Yuetan Subdistirct for at least 1 year

• Having, in association with a documented or strongly suspected infection and fullfil the diagnostic criteria of sepsis according to the "Surviving Sepsis Campaign:International guidelines for management of severe sepsis and septic shock:2012"

Exclusion Criteria:

• Age<18 years

• Lived in Yuetan Subdistrict less than 1 year

Study Design

Observational Model: Ecologic or Community, Time Perspective: Prospective

Related Conditions & MeSH terms

• Sepsis
• Toxemia

Locations

Country	Name	City	State
China	MICU of Peking Union Medical College Hospital	Beijing	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
Peking Union Medical College Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	incidence of sepsis of people living in Yuetan subdistrict in Beijing		2012-7-1~2014-6-30, up to 2 years	Yes